跳至主要内容
临床试验/JPRN-UMIN000020288
JPRN-UMIN000020288已完成未知

Intervention Study of Istradefylline for the Treatment of Gait Disorders in Patients with Parkinson's Disease. - Intervention Study of Istradefylline for the Treatment of Gait Disorders in Patients with Parkinson's Disease.

Juntendo University Shizuoka Hospital0 个研究点目标入组 30 人开始时间: 2015年12月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Dementia or a score of <=23 on the Mini-Mental State Examination (MMSE) 2)Gait disturbance due to causes other than the underlying disease 3)Severe dyskinesia as assessed by the investigator or subinvestigator 4)Current treatment with istradefylline 5)Moderate to severe hepatic disorder or current treatment with a strong inhibitor of CYP3A4 6)Ongoing treatment with deep brain stimulation (DBS) and a condition requiring stimulation 7)Lactating, pregnant, or possibly pregnant women 8)Other conditions judged by the investigator or subinvestigator to be unsuitable for participation in the research

研究者

相似试验